BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 10925293)

  • 21. A Toxoplasma gondii vaccine encoding multistage antigens in conjunction with ubiquitin confers protective immunity to BALB/c mice against parasite infection.
    Yin H; Zhao L; Wang T; Zhou H; He S; Cong H
    Parasit Vectors; 2015 Sep; 8():498. PubMed ID: 26420606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant pseudorabies virus carrying a plasmodium gene: herpesvirus as a new live viral vector for inducing T- and B-cell immunity.
    Sedegah M; Chiang CH; Weiss WR; Mellouk S; Cochran MD; Houghten RA; Beaudoin RL; Smith D; Hoffman SL
    Vaccine; 1992; 10(9):578-84. PubMed ID: 1323900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant Toxoplasma gondii phosphoglycerate mutase 2 confers protective immunity against toxoplasmosis in BALB/c mice.
    Wang HL; Wen LM; Pei YJ; Wang F; Yin LT; Bai JZ; Guo R; Wang CF; Yin GR
    Parasite; 2016; 23():12. PubMed ID: 26984115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes.
    Wang R; Charoenvit Y; Corradin G; De La Vega P; Franke ED; Hoffman SL
    J Immunol; 1996 Nov; 157(9):4061-7. PubMed ID: 8892640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Linear and multiple antigen peptides containing defined T and B epitopes of the Plasmodium yoelii circumsporozoite protein: antibody-mediated protection and boosting by sporozoite infection.
    Marussig M; Rénia L; Motard A; Miltgen F; Pétour P; Chauhan V; Corradin G; Mazier D
    Int Immunol; 1997 Dec; 9(12):1817-24. PubMed ID: 9466309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity and protective efficacy of a recombinant yellow fever vaccine against the murine malarial parasite Plasmodium yoelii.
    Stoyanov CT; Boscardin SB; Deroubaix S; Barba-Spaeth G; Franco D; Nussenzweig RS; Nussenzweig M; Rice CM
    Vaccine; 2010 Jun; 28(29):4644-52. PubMed ID: 20451637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model.
    Doolan DL; Hoffman SL
    J Immunol; 1999 Jul; 163(2):884-92. PubMed ID: 10395683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon-gamma-independent CD8+ T cell-mediated protective anti-malaria immunity elicited by recombinant adenovirus.
    Rodrigues EG; Claassen J; Lee S; Wilson JM; Nussenzweig RS; Tsuji M
    Parasite Immunol; 2000 Mar; 22(3):157-60. PubMed ID: 10672197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The dendritic cell-specific chemokine, dendritic cell-derived CC chemokine 1, enhances protective cell-mediated immunity to murine malaria.
    Bruna-Romero O; Schmieg J; Del Val M; Buschle M; Tsuji M
    J Immunol; 2003 Mar; 170(6):3195-203. PubMed ID: 12626578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA vaccination with a gene encoding Toxoplasma gondii Rhoptry Protein 17 induces partial protective immunity against lethal challenge in mice.
    Wang HL; Wang YJ; Pei YJ; Bai JZ; Yin LT; Guo R; Yin GR
    Parasite; 2016; 23():4. PubMed ID: 26842927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant canine adenovirus type-2 expressing TgROP16 provides partial protection against acute Toxoplasma gondii infection in mice.
    Li XZ; Lv L; Zhang X; Anchang KY; Abdullahi AY; Tu L; Wang X; Xia L; Zhang XX; Feng W; Lu C; Li S; Yuan ZG
    Infect Genet Evol; 2016 Nov; 45():447-453. PubMed ID: 27742446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity and protection of a recombinant human adenovirus serotype 35-based malaria vaccine against Plasmodium yoelii in mice.
    Ophorst OJ; Radosević K; Havenga MJ; Pau MG; Holterman L; Berkhout B; Goudsmit J; Tsuji M
    Infect Immun; 2006 Jan; 74(1):313-20. PubMed ID: 16368986
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Daniel S; Pichugin A; Torano H; Renn JP; Kwan J; Cowles MV; Conteh S; Lambert LE; Alani N; MacDonald NJ; Dai W; Highsmith K; Anderson C; Gorres JP; Musgrove J; Butler B; Althubaiti N; Dixit S; Zarling-Bejma S; Krzych U; Duffy PE
    Infect Immun; 2021 Oct; 89(11):e0016521. PubMed ID: 34310889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of protective immunity induced by DNA vaccination with genes encoding Toxoplasma gondii GRA17 and GRA23 against acute toxoplasmosis in mice.
    Zhu WN; Wang JL; Chen K; Yue DM; Zhang XX; Huang SY; Zhu XQ
    Exp Parasitol; 2017 Aug; 179():20-27. PubMed ID: 28625894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Actively induced antigen-specific CD8+ T cells by epitope-bearing parasite pre-infection but not prime/boost virus vector vaccination could ameliorate the course of Plasmodium yoelii blood-stage infection.
    Ono T; Yamaguchi Y; Oguma T; Takayama E; Takashima Y; Tadakuma T; Miyahira Y
    Vaccine; 2012 Sep; 30(44):6270-8. PubMed ID: 22902783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemically attenuated Plasmodium sporozoites induce specific immune responses, sterile immunity and cross-protection against heterologous challenge.
    Purcell LA; Wong KA; Yanow SK; Lee M; Spithill TW; Rodriguez A
    Vaccine; 2008 Sep; 26(38):4880-4. PubMed ID: 18672017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of protective CTL responses against the Plasmodium yoelii circumsporozoite protein by immunization with peptides.
    Franke ED; Corradin G; Hoffman SL
    J Immunol; 1997 Oct; 159(7):3424-33. PubMed ID: 9317141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccination with Toxoplasma gondii calcium-dependent protein kinase 6 and rhoptry protein 18 encapsulated in poly(lactide-co-glycolide) microspheres induces long-term protective immunity in mice.
    Zhang NZ; Xu Y; Wang M; Chen J; Huang SY; Gao Q; Zhu XQ
    BMC Infect Dis; 2016 Apr; 16():168. PubMed ID: 27090890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice.
    Zheng B; Lu S; Tong Q; Kong Q; Lou D
    Vaccine; 2013 Sep; 31(41):4578-84. PubMed ID: 23928460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Co-expression of Interleukin-15 Enhances the Protective Immune Responses Induced by Immunization with a Murine Malaria MVA-Based Vaccine Encoding the Circumsporozoite Protein.
    Parra M; Liu X; Derrick SC; Yang A; Molina-Cruz A; Barillas-Mury C; Zheng H; Thao Pham P; Sedegah M; Belmonte A; Litilit DD; Waldmann TA; Kumar S; Morris SL; Perera LP
    PLoS One; 2015; 10(10):e0141141. PubMed ID: 26505634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.